Vanguard Total Stock Market Index Fund ETF vs GeneDx Holdings Corp — how do they compare? Vanguard Total Stock Market Index Fund ETF trades at $369.52, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| VTI | WGS | |
|---|---|---|
52-Week High | $374.36 | $167.51 |
52-Week Low | $305.74 | $34.51 |
Market Cap | — | $1.80B |
Sector | — | Technology |
Enterprise Value | — | $1.80B |
Trailing returns across standard periods
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →